- Category Marryalyan
- DATE 25 Feb 2025
Cancer Symptom Trials and Palliative Care Clinical Studies Collaborative
February 2025

PaCCSC & CST Research Forum 2025
The Science behind the Art of care: Clinical trials in cancer symptoms and palliative care
27-28 March 2025 | ICC, Sydney
We’re excited to invite you to the PaCCSC & CST Research Forum 2025, where we’ll explore the scientific foundations that inform best practices in cancer symptom management and palliative care.
We are thrilled to welcome three international keynote speakers to the forum:
-
- Professor William Dale, Geriatric Medicine, USA
- Professor Catherine Walshe, Palliative Care, UK
- Professor Steve Pantilat, Palliative Care, USA
This event is for researchers, healthcare professionals and consumers with experience or interest in palliative care or cancer symptom management research.
We invite you to take this opportunity to connect with leading experts and build your networks in palliative care and cancer symptom management research.
Register now
Email enquiries to [email protected]
Expressions of interest – Join a PaCCSC & CST Symptom Node Subcommittee
Help shape the future of palliative care and cancer symptom management
Researchers, clinicians and consumers with an interest in palliative care and/or cancer symptom management are invited to express interest in joining a PaCCSC & CST Symptom Node Subcommittee
Our seven Symptom Node Subcommittees (SNSCs) each lead a dedicated research program focused on a specific symptom:
-
- Appetite and cachexia
- Breathlessness and sleep
- Cognitive and neurological disorders
- Fatigue
- Gut dysfunction
- Nausea
- Pain
This is an excellent opportunity to extend your personal research profile as part of a collaborative research team, while contributing to better quality-of-life outcomes for patients and families.
Hannah Wardill, Chair, Gut Dysfunction Symptom Node SubCommittee
We'd love to hear from you if:
-
- you have an interest in collaborating on a research program investigating one or more symptoms and its impacts on people with cancer or in palliative care
- have capacity to be committed and engaged to support the work of the node.
Commitment
Term of membership: two years Meeting schedule: quarterly 1-hour meetings. For questions or to express interest in joining an SNSC, please email [email protected]
IMPACCT Rapid Program
The IMPACCT Rapid Program is a collaborative international quality improvement program that studies the prospective use of medications and non-pharmacological interventions commonly used in palliative care and cancer symptom management.
Participating in the program provides an opportunity to develop the capacity and research capabilities of you and your staff who may not otherwise have the opportunity to engage in research.
Adult series
Pancreatic Enzyme Replacement Therapy (PERT) for pancreatic cancer – series 53
The PERT for pancreatic cancer Rapid series is open for recruitment. This study aims to explore clinicians’ prescribing practices and evaluate the efficacy and safety of PERT for people with pancreatic cancer. PERT is a biological medication administered in capsule form to treat pancreatic exocrine insufficient (PEI) as it aids digestion.
Research suggests that PERT is well tolerated and helps with symptom management, weight stabilisations, toleration of oncology treatments and even survival. However, published literature indicates that prescribing rates are low globally among clinicians treating people with pancreatic cancer.
Paediatric series
Ketamine for cancer-related mucositis pain – series 42
In this series, we are seeking to establish the broad utility and toxicity of ketamine for children with chronic non-cancer pain and cancer pain in real-life situations.
Ketamine is widely used for paediatric general and regional anaesthesia, procedural sedation, as an adjunct to opioid analgesia, and as a low-dose continuous infusion for the treatment of both acute and complex pain.
If you can help us to collect data to improve the available evidence about the effectiveness of ketamine for children with cancer-related mucositis pain, please get in touch.
To express interest in participating in these series or to learn more about other series in the IMPACCT Rapid Program, visit uts.edu.au/rapid or email [email protected]
Join Australia's leading oncology community & make an impact
Become a COSA memberTwitter
@COSAoncology
Follow

COSAoncology yesterday
@COSAoncology @ASCO @EuropeanCancer are using their collective voices to raise awareness of challenges impacting the wellbeing of health professionals and to define principles for creating healthy workplace cultures in health systems. See Lancet Oncology
Read More >
COSAoncology 2 days ago
Exercise & Cancer / Global Oncology Group Fellowship opportunities! COSA is offering two Fellowships to early-mid career researchers to coordinate and lead a study to develop a model of care for exercise oncology for a lower-middle-income country setting.
Read More >
COSAoncology 3 days ago
The latest Survivorship eNews is out now! With working group updates, new COSA-endorsed resources, journal articles, COSA-IPOS 2025 key survivorship sessions & more. Check your inbox, visit
Read More >
COSAoncology 3 days ago
Cancer Pharmacists Group Fellowship opportunity! COSA is offering an early career researcher mentorship, guidance and support to develop a COSA position statement on 'Documentation of Hypersensitivity Reactions to SACT'. Find out more
Read More >
COSAoncology 7 days ago
Congratulations @Joanne472 recipient of the 2025 Melanie Price Psycho-Oncology Award and Dr Sarah Ellis recipient of the 2025 Phyllis Butow New Investigator Award. Join us in recognising their achievements at COSA-IPOS 2025 in Adelaide in November.
Read More >
COSAoncology 15 days ago
Congrats Prof Gail Garvey AM recipient of 2025 Tom Reeve Award for Outstanding Contribution to Cancer Care. Her work has contributed greatly to policy and practice changes to improve the outcomes of First Nation's people with cancer. Presentation & oration
Read More >
COSAoncology 22 days ago
Our August member newsletter is out now. Check your inbox for COSA news and updates – webinars, resources, opportunities, journal articles and events. Or log in and read it online anytime at
Read More >
COSAoncology 27 days ago
Earlybird closes in 1 week! Don't miss the exciting program and networking opportunities at #COSAIPOS2025 this November in beautiful Adelaide. With support from #Adelaide, @BizEventsAdl, @AdelaideCC. View the program
Read More >
COSAoncology 28 days ago
Join us for a collaborative webinar exploring nurse-led survivorship care models and their role in addressing pressures in the health system. Ideal for multidisciplinary cancer care teams looking to embed sustainable, outcomes-focused survivorship care.
Read More >
COSAoncology 29 days ago
In partnership with @CancerCouncilOz, we’re offering three grants up to AUD$3,300 to support Aboriginal and Torres Strait Islander delegates to attend #COSAIPOS2025 in Adelaide this November. Applications close in one week. Apply now
Read More >